Business Context and Reporting Period
Company: iTonic Holdings Ltd (formerly Pheton Holdings Ltd)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: iTonic is a Cayman Islands holding company conducting operations primarily through its PRC subsidiary, Beijing Feitian. The company develops and commercializes Treatment Planning Systems (TPS) for brachytherapy (radioactive particle implantation) and sells medical auxiliary supplies. In late 2025, the company acquired a 51% interest in iTonic Corporation, a U.S.-based automated home health technology company.
Key Financial Metrics (Fiscal Year Ended Dec 31, 2025)
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Revenue | $523,031 | $448,196 | $628,591 |
| Gross Profit | $327,351 | $381,155 | $470,828 |
| Gross Margin | 62.59% | 85.04% | 74.90% |
| Net Loss | $(5,098,384) | $(660,588) | $(241,217) |
| Operating Expenses | $5,514,314 | $1,151,421 | $777,508 |
| Cash and Restricted Cash | $1,490,129 | $6,159,823 | $227,450 |
| Working Capital | $3,625,621 | N/A | N/A |
| Short-Term Debt | $142,998 | $247,969 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 16.7% year-over-year to $523,031, driven primarily by a 103.7% surge in sales of Medical Auxiliary Supplies ($160,181). Conversely, revenue from the core FTTPS software product declined slightly by 1.8% due to a 17% drop in sales volume, partially offset by an 18% increase in average contract prices.
- Profitability Deterioration: Net loss widened significantly by 671.8% to $5.1 million. This was driven by a 378.9% increase in total operating expenses to $5.5 million.
- Expense Drivers: General and Administrative (G&A) expenses skyrocketed 549.3% to $4.9 million, attributed to professional service fees (audit, legal, accounting) associated with public company status and the acquisition of iTonic Corporation. R&D expenses increased 392.0% to $459,135 due to AI feature development.
- Liquidity: Cash and restricted cash decreased by approximately $4.7 million to $1.5 million, reflecting a net cash outflow of $3.2 million from operating activities and $1.4 million from investing activities.
- Acquisition: The company acquired 51% of iTonic Corporation in November 2025, recording $1.96 million in goodwill and $2.41 million in intangible assets (customer relationships).
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Outlook
Management plans to fund operations through revenue generation, intensified sales strategies, and potential additional equity or debt financing. The company intends to expand into Southeast Asian markets and develop AI-driven surgical robotic devices. A private placement of 100 million Class A shares at $0.20 per share was announced in March 2026 (subsequent event) to raise capital.
Going Concern Warning
The auditors and management have raised substantial doubt regarding the company's ability to continue as a going concern. The company incurred a net loss of $5.1 million and negative operating cash flows in 2025. Continued operations depend on securing additional short-term capital.
Material Weaknesses in Internal Controls
The company identified three material weaknesses in internal control over financial reporting as of December 31, 2025:
- Insufficient in-house accounting personnel with knowledge of U.S. GAAP and SEC reporting rules.
- Lack of formal policies and procedures for risk assessment and internal control frameworks.
- Deficiencies in Information Technology general controls (access management, change management, cybersecurity).
Key Risks
- Regulatory (PRC): Risks related to PRC government oversight, cybersecurity reviews, and potential restrictions on foreign investment or data transfer.
- Customer Concentration: The top two customers accounted for 51% of total revenue in 2025.
- Supplier Concentration: Two suppliers accounted for 68% of total purchases in 2025.
- Trade Relations: Escalating U.S.-China trade tensions and tariffs could disrupt supply chains and increase costs.
Investor Verification Checklist
- Going Concern Status: Verify the company's ability to secure the additional financing required to sustain operations beyond the next 12 months.
- Internal Control Remediation: Monitor progress in hiring qualified accounting staff and implementing IT general controls to address the identified material weaknesses.
- Revenue Sustainability: Assess the sustainability of the revenue spike in Medical Auxiliary Supplies versus the decline in core FTTPS software sales volume.
- Private Placement Impact: Evaluate the dilution impact of the announced March 2026 private placement (100 million shares at $0.20) on existing shareholders.
- Acquisition Integration: Review the performance milestones and integration progress of the newly acquired iTonic Corporation.